Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CKD-846 by Chong Kun Dang Pharmaceutical for Benign Prostatic Hyperplasia: Likelihood of Approval
CKD-846 is under clinical development by Chong Kun Dang Pharmaceutical and currently in Phase I for Benign Prostatic Hyperplasia. According...